Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Search results

22 projects found matching your search criteria :

  1. Integrity of E3 ubiquitin ligase complex as a biomarker of response to treatment with immunomodulatory drugs in patients...

    Call: OPUS 7 , Panel: NZ5

    Principal investigator: dr hab. Ewa Lech-Marańda

    Instytut Hematologii i Transfuzjologii

  2. Characteristics of neuropilin-1 (NRP1) as a target of antiangiogenic activity of immunomodulatory drugs in multiple myel...

    Call: OPUS 7 , Panel: NZ6

    Principal investigator: prof. Krzysztof Giannopoulos

    Uniwersytet Medyczny w Lublinie, II Wydział Lekarski z Oddziałem Anglojęzycznym

  3. Analysis of the effect of the DIS3 mutations on the viability, development and tumor formation in mice

    Call: HARMONIA 5 , Panel: NZ4

    Principal investigator: dr hab. Andrzej Dziembowski

    Instytut Biochemii i Biofizyki PAN

  4. The influence of hypoxia on functional features of multiple myeloma cells

    Call: PRELUDIUM 5 , Panel: NZ1

    Principal investigator: dr Kinga Kocemba

    Uniwersytet Jagielloński- Collegium Medicum, Collegium Medicum, Wydział Lekarski

  5. Lipid antigens as a target for autoimmune attack in multiple sclerosis.

    Call: HARMONIA 4 , Panel: NZ3

    Principal investigator: dr Maria Podbielska

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda PAN

  6. EBI2 receptor as a new myelin repair therapy in multiple sclerosis.

    Call: SONATA 18 , Panel: NZ3

    Principal investigator: dr Aleksandra Rutkowska

    Gdański Uniwersytet Medyczny, Centrum Chorób Mózgu

  7. The role of the gut microbiota in the pathogenesis of plasma cell dyscrasias

    Call: PRELUDIUM 21 , Panel: NZ6

    Principal investigator: Marcin Jasiński

    Warszawski Uniwersytet Medyczny

  8. Uracil in DNA and aberrant DNA methylation/hydroxymethylation as a new biomarkers of multiple myeloma development? A sea...

    Call: OPUS 20 , Panel: NZ5

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

  9. Gankyrin protein as a new potential therapeutic target in multiple myeloma

    Call: OPUS 18 , Panel: NZ5

    Principal investigator: dr Irena Misiewicz-Krzemińska

    Instytut Hematologii i Transfuzjologii

  10. Role of the human RNA exosome catalytic subunit DIS3 in multiple myeloma pathogenesis and cell physiology.

    Call: MAESTRO 1 , Panel: NZ1

    Principal investigator: prof. Andrzej Dziembowski

    Uniwersytet Warszawski, Wydział Biologii

  11. How dysfunction in the nuclear, RNA degrading enzyme DIS3 leads to mitotic defects creating a possible therapeutic strat...

    Call: SONATINA 3 , Panel: NZ2

    Principal investigator: dr Tomasz Kuliński

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie

  12. The role of PIM kinases in the vascular niche of multiple myeloma

    Call: PRELUDIUM 16 , Panel: NZ5

    Principal investigator: Filip Garbicz

    Instytut Hematologii i Transfuzjologii

  13. Determining the role of basigin in multiple myeloma and acute myeloid leukaemia development

    Call: PRELUDIUM 15 , Panel: NZ5

    Principal investigator: Piotr Łacina

    Instytut Immunologii i Terapii Doświadczalnej im. Ludwika Hirszfelda Polskiej Akademii Nauk

  14. Association of TXNDC5 and calreticulin with decreased ER stress, allowing resistant multiple myeloma cells to by-pass pr...

    Call: PRELUDIUM 15 , Panel: NZ5

    Principal investigator: Tadeusz Kubicki

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski

  15. Cognitive functioning of patients with multiple myeloma and biological factors as well as psychosocial variables shaping...

    Call: PRELUDIUM 14 , Panel: HS6

    Principal investigator: Magdalena Bury-Kamińska

    Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Pedagogiki i Psychologii

  16. The role of Fam46C in B cell phisiology

    Call: OPUS 14 , Panel: NZ2

    Principal investigator: dr Seweryn Mroczek

    Uniwersytet Warszawski, Wydział Biologii

  17. Determination of arginase-1 as a potential drug target in the treatment of multiple myeloma and in reducing proteasome i...

    Call: OPUS 13 , Panel: NZ6

    Principal investigator: prof. Jakub Gołąb

    Warszawski Uniwersytet Medyczny, Wydział Lekarski

  18. Proteomic analysis of myeloma plasma cells to determine proteins and pathways involved in acquired resistance to proteas...

    Call: OPUS 13 , Panel: NZ5

    Principal investigator: dr hab. Dominik Dytfeld

    Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Lekarski

  19. Evaluation of primary and secondary molecular disorders determinig drug resistance from a group of proteasome inhibitors...

    Call: OPUS 12 , Panel: NZ5

    Principal investigator: prof. Tadeusz Robak

    Uniwersytet Medyczny w Łodzi, Wydział Lekarski

  20. The role of neurotrophins and angiogenic cytokines in the pathophysiology of treatment-induced peripheral neuropathy in ...

    Call: OPUS 12 , Panel: NZ7

    Principal investigator: prof. Bogusław Machaliński

    Pomorski Uniwersytet Medyczny w Szczecinie, Wydział Medycyny i Stomatologii

  21. Oncogenic mechanisms of DIS3 mutations

    Call: MAESTRO 8 , Panel: NZ4

    Principal investigator: prof. Andrzej Dziembowski

    Międzynarodowy Instytut Biologii Molekularnej i Komórkowej w Warszawie

  22. Evaluation of anticancer potential of glutamine metabolism modulation in multiple myeloma sensitive and resistant to che...

    Call: PRELUDIUM 11 , Panel: NZ5

    Principal investigator: Monika Prełowska

    Uniwersytet Warszawski, Centrum Nowych Technologii Uniwersytetu Warszawskiego